The persistence of the ductus arteriosus in preterm infants is a well‐documented contributor to morbidity, as the failure of this fetal vessel to close can result in significant haemodynamic ...
Background Ibuprofen treatment of patent ductus arteriosus (PDA) has been shown to be as effective as indomethacin in small randomized controlled trials, with possibly fewer adverse effects. However, ...
Early treatment with ibuprofen for a large patent ductus arteriosus did not result in a lower risk of death or moderate or severe bronchopulmonary dysplasia than placebo at 36 weeks of postmenstrual ...
Hosted on MSN
Expectant management matches active treatment in preemies with patent ductus arteriosus
WEDNESDAY, Dec. 17, 2025 (HealthDay News) -- For extremely preterm infants with protocol-defined patent ductus arteriosus (PDA), the incidence of death or bronchopulmonary dysplasia (BPD) does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results